DrMatthew Palframan
Senior Lecturer in Pharmaceutical and Medicinal Chemistry
Faculty of Science and Engineering
Orcid identifier0000-0003-0797-1646 (opens in a new tab)
- Senior Lecturer in Pharmaceutical and Medicinal ChemistryFaculty of Science and Engineering
- 01902 32 Ext.2307
- University of Wolverhampton, School of Pharmacy, Wulfruna Street, Wolverhampton, United Kingdom
BIO
Dr Matthew J Palframan joined the University of Wolverhampton in September 2019, as a Lecturer in Pharmaceutical Chemistry in the School of Pharmacy, at the University of Wolverhampton.
Matthew Palframan graduated from Oxford University with an MChem, and then carried out research with Professor Andy Parsons at the University of York on radical approaches towards the synthesis of alkaloids leading to a PhD in 2010. He subsequent moved to the University of Bath to conduct post-doctoral research exploiting the products of microbial oxidation's in synthesis with Dr Simon Lewis. Matthew then joined the research group of Professor Pattenden in Nottingham where he explored biomimetic intramolecular cycloaddition reactions for the construction of complex ring systems found in diterpenes. In 2014 Matthew remained at Nottingham University, taking up an appointment as a medicinal chemist in the labs of Profs. Chris Hayes and David Brook, developing new therapeutic agents to treat Myotonic Dystrophy.
Matthew Palframan graduated from Oxford University with an MChem, and then carried out research with Professor Andy Parsons at the University of York on radical approaches towards the synthesis of alkaloids leading to a PhD in 2010. He subsequent moved to the University of Bath to conduct post-doctoral research exploiting the products of microbial oxidation's in synthesis with Dr Simon Lewis. Matthew then joined the research group of Professor Pattenden in Nottingham where he explored biomimetic intramolecular cycloaddition reactions for the construction of complex ring systems found in diterpenes. In 2014 Matthew remained at Nottingham University, taking up an appointment as a medicinal chemist in the labs of Profs. Chris Hayes and David Brook, developing new therapeutic agents to treat Myotonic Dystrophy.
UNIVERSITY OF WOLVERHAMPTON APPOINTMENTS
- Lecturer in Pharmaceutical ChemistryUniversity of Wolverhampton, Wolverhampton, United Kingdom1 Sep 2019
DEGREES
- PhDUniversity of York, York, United Kingdom1 Sep 2016 - 30 Sep 2010
- MChemUniversity of Oxford, Oxford, United Kingdom1 Sep 2002 - 30 Jul 2006